{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:35:11Z","timestamp":1793115311107,"version":"4.5.0"},"reference-count":28,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Frailty influences treatment outcomes in older patients with multiple myeloma (MM), yet existing frailty tools capture limited geriatric domains and are incompletely studied in the context of contemporary therapies. We prospectively evaluated patient-reported comprehensive geriatric assessment (CGA) domains and their associations with treatment toxicity and patient-reported outcomes (PRO) in older adults with MM. Patients aged \u226560 years with newly diagnosed or relapsed\/refractory MM initiating a new therapy completed electronic CGA and PRO questionnaires at baseline and 4 months. Outcomes included clinician- and patient-reported treatment toxicity, treatment adaptations, health care use, and health-related quality of life (HRQOL). A cumulative deficit frailty index (FI) was derived from CGA and HRQOL domains. Among 90 patients (mean age, 72 years), geriatric impairments were common, particularly physical function domains. High-grade nonhematologic toxicities were significantly associated with older age, comorbidities, patient-reported functional limitations, and anxiety. Toxicity rates on the PRO version of the Common Terminology Criteria for Adverse Events (CTCAE) were higher than on CTCAE, highlighting a discordance between physician- and patient-reported treatment toxicity. Frailty was present in 22% and associated with worse baseline HRQOL and increased high-grade nonhematologic toxicity but not treatment adaptations or health care use. Average CGA and HRQOL scores remained stable over 4 months, although individual trajectories varied. Patient-reported geriatric impairments are prevalent in older adults with MM and strongly associated with nonhematologic toxicities even in the contemporary treatment era. Physician-reported CTCAE may not fully reflect patients' symptom burden. Heterogeneity in individual geriatric trajectories during treatment emphasize the need for longitudinal assessment. This study was registered at www.clinicaltrials.gov as NCT05918185.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2026020579","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T01:18:46Z","timestamp":1785201526000},"page":"6957-6967","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Self-reported geriatric impairments and treatment toxicity in older patients with multiple myeloma"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-1589","authenticated-orcid":false,"given":"Nadine","family":"Abdallah","sequence":"first","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalyn","family":"Marar","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1601-9163","authenticated-orcid":false,"given":"Claire","family":"Yee","sequence":"additional","affiliation":[{"name":"2Department of Quantitative and Health Sciences, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bodily","sequence":"additional","affiliation":[{"name":"2Department of Quantitative and Health Sciences, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Truman","sequence":"additional","affiliation":[{"name":"2Department of Quantitative and Health Sciences, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Wildes","sequence":"additional","affiliation":[{"name":"3Division of Hematology, University of Nebraska Medical Center\/Nebraska Medicine, Omaha, NE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3095-2590","authenticated-orcid":false,"given":"Terri","family":"Menser","sequence":"additional","affiliation":[{"name":"4Division of Health Care Delivery Research, Kern Center for the Science of Health Care Delivery, Mayo Clinic, Jacksonville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-0123","authenticated-orcid":false,"given":"Megan","family":"Weivoda","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Aug","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byron","family":"Smith","sequence":"additional","affiliation":[{"name":"5Department of Health Sciences Research, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3214-0203","authenticated-orcid":false,"given":"Francis","family":"Buadi","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Kapoor","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8780-9512","authenticated-orcid":false,"given":"Angela","family":"Dispenzieri","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Hayman","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dingli","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Gonsalves","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5335-9533","authenticated-orcid":false,"given":"Joselle","family":"Cook","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-8453","authenticated-orcid":false,"given":"Saurabh","family":"Zanwar","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9014-9658","authenticated-orcid":false,"given":"Moritz","family":"Binder","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8573-9434","authenticated-orcid":false,"given":"Taxiarchis","family":"Kourelis","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-5196","authenticated-orcid":false,"given":"Morie","family":"Gertz","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-0326","authenticated-orcid":false,"given":"Rahma","family":"Warsame","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lin","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Vincent","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9912-1085","authenticated-orcid":false,"given":"Amylou","family":"Dueck","sequence":"additional","affiliation":[{"name":"2Department of Quantitative and Health Sciences, Mayo Clinic, Scottsdale, AZ"},{"name":"6Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5392-9284","authenticated-orcid":false,"given":"Shaji","family":"Kumar","sequence":"additional","affiliation":[{"name":"1Division of Hematology, Mayo Clinic, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,10,15]]},"reference":[{"issue":"13","key":"2026102711114598100_bib1","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2026102711114598100_bib2","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41375-019-0539-0","article-title":"A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial","volume":"34","author":"Facon","year":"2020","journal-title":"Leukemia"},{"issue":"7","key":"2026102711114598100_bib3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1038\/s41375-020-0713-4","article-title":"Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities","volume":"34","author":"Stege","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"2026102711114598100_bib4","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/ajh.24532","article-title":"N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma","volume":"91","author":"Milani","year":"2016","journal-title":"Am J Hematol"},{"issue":"3","key":"2026102711114598100_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3324\/haematol.2020.254235","article-title":"Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial","volume":"106","author":"Sandra","year":"2020","journal-title":"Haematologica"},{"issue":"10","key":"2026102711114598100_bib6","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1200\/JCO.2010.30.6985","article-title":"Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401","volume":"29","author":"Hurria","year":"2011","journal-title":"J Clin Oncol"},{"issue":"2","key":"2026102711114598100_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1200\/JCO.2002.20.2.494","article-title":"Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study","volume":"20","author":"Repetto","year":"2002","journal-title":"J Clin Oncol"},{"issue":"5","key":"2026102711114598100_bib8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/bloodadvances.2024014624","article-title":"Cumulative deficits frailty index and relationship status predict survival in multiple myeloma","volume":"9","author":"Abdallah","year":"2025","journal-title":"Blood Adv"},{"issue":"1","key":"2026102711114598100_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41408-023-00843-5","article-title":"Dynamic frailty risk assessment among older adults with multiple myeloma: a population-based cohort study","volume":"13","author":"Mian","year":"2023","journal-title":"Blood Cancer J"},{"issue":"17","key":"2026102711114598100_bib10","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.3390\/cancers17172904","article-title":"Comprehensive geriatric assessment of older patients with multiple myeloma: a prospective observational study","volume":"17","author":"Sobrini-Morillo","year":"2025","journal-title":"Cancers"},{"issue":"5","key":"2026102711114598100_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood.2024025868","article-title":"Beyond static measurements: dynamic frailty improves survival prediction in multiple myeloma","volume":"145","author":"Smits","year":"2025","journal-title":"Blood"},{"issue":"9","key":"2026102711114598100_bib12","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cncr.21422","article-title":"Developing a cancer-specific geriatric assessment: a feasibility study","volume":"104","author":"Hurria","year":"2005","journal-title":"Cancer"},{"key":"2026102711114598100_bib13","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0. Accessed 29 August 2021. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf."},{"issue":"1","key":"2026102711114598100_bib14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin Trials"},{"issue":"1","key":"2026102711114598100_bib15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jgs.18054","article-title":"Patient-reported geriatric assessment-based frailty index among older adults with gastrointestinal malignancies","volume":"71","author":"Giri","year":"2023","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"2026102711114598100_bib16","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"5","key":"2026102711114598100_bib17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/jgs.15715","article-title":"Geriatric assessment in older adults with multiple myeloma","volume":"67","author":"Wildes","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"2026102711114598100_bib18","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1080\/10428194.2024.2340052","article-title":"Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)","volume":"65","author":"Haider","year":"2024","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"2026102711114598100_bib19","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jgo.2022.04.010","article-title":"Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders","volume":"13","author":"Nakamura","year":"2022","journal-title":"J Geriatr Oncol"},{"issue":"12","key":"2026102711114598100_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.clml.2022.08.002","article-title":"Longitudinal analysis of patient-reported cognitive function in multiple myeloma","volume":"22","author":"Yusuf","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"2026102711114598100_bib21","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3324\/haematol.2022.281489","article-title":"An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence","volume":"108","author":"Holler","year":"2023","journal-title":"Haematologica"},{"issue":"4","key":"2026102711114598100_bib22","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1200\/JCO.1998.16.4.1582","article-title":"Comorbidity and functional status are independent in older cancer patients","volume":"16","author":"Extermann","year":"1998","journal-title":"J Clin Oncol"},{"issue":"1","key":"2026102711114598100_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41408-021-00602-4","article-title":"Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based study","volume":"12","author":"Mian","year":"2022\/01\/27 2022","journal-title":"Blood Cancer J"},{"issue":"suppl 1","key":"2026102711114598100_bib24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1182\/blood-2022-165524","article-title":"Health-related quality of life for frail transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone: subgroup analysis of MAIA trial","volume":"140","author":"Perrot","year":"2022","journal-title":"Blood"},{"key":"2026102711114598100_bib25","doi-asserted-by":"crossref","first-page":"114153","DOI":"10.1016\/j.ejca.2024.114153","article-title":"Quality of life gains in frail and intermediate-fit patients with multiple myeloma: findings from the prospective HOVON123 clinical trial","volume":"207","author":"Seefat","year":"2024","journal-title":"Eur J Cancer"},{"issue":"6","key":"2026102711114598100_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.clml.2023.03.005","article-title":"Impact of disease progression, line of therapy, and response on health-related quality of life in multiple myeloma: a systematic literature review","volume":"23","author":"Fonseca","year":"2023","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"2026102711114598100_bib27","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.clml.2020.10.002","article-title":"Real-world evaluation of health-related quality of life in patients with multiple myeloma from Germany","volume":"21","author":"Engelhardt","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"1","key":"2026102711114598100_bib28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ejh.12882","article-title":"A systematic review of health-related quality of life in longitudinal studies of myeloma patients","volume":"99","author":"Nielsen","year":"2017","journal-title":"Eur J Haematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/20\/6957\/2595227\/blooda_adv-2026-020579-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/20\/6957\/2595227\/blooda_adv-2026-020579-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:11:55Z","timestamp":1793113915000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/20\/6957\/569890\/Self-reported-geriatric-impairments-and-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":28,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2026020579","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,27]]},"published":{"date-parts":[[2026,10,15]]}}}